In 2016, the Movement Disorder Society Task Force for the Nomenclature of Genetic
Movement Disorders presented a new system for naming genetically determined movement …

Genetic factors, environmental factors, and gene–environment interactions have been found
to modify PD risk, age at onset (AAO), and disease progression. The objective of this study …

Parkinson’s disease (PD) is a progressive neurodegenerative disorder. Genetic modifiers,
environmental factors and gene–environment interactions have been found to modify PD risk …

The study of social dominance interactions between animals offers a window onto the
decision-making involved in establishing dominance hierarchies and an opportunity to examine …

Introduction There have been no specific guidelines regarding which genes should be tested
in the clinical setting for Parkinson's disease (PD) or parkinsonism. We evaluated the types …

Background A mitochondrial polygenic score (MGS) is composed of genes related to
mitochondrial function and found to be associated with Parkinson's disease (PD) risk. Objective To …

Background GBA1 variants are the strongest genetic risk factor for Parkinson’s disease (PD).
However, the pathogenicity of GBA1 variants concerning PD is still not fully understood. …

The objective of our study was to investigate the impact of the mitochondrial polygenic score
(MGS) and lifestyle/environmental data on age at onset in LRRK2 p.Gly2019Ser …

Objective To investigate the association between a Parkinson’s disease (PD)-specific
polygenic score (PGS) and protective lifestyle factors on age at onset (AAO) in PD. Methods We …

… Today, a PhD candidate from our institute, Carolin Gabbert, will present an overview of how
… Gabbert: Stock Ownership in medically-related fields: None; Intellectual Property Rights: …